USPTO 2015–2025 USPTO PatentsView US Corporation

Fresenius Medical Care Holdings, Inc.

USPTO PatentsView assignee record - 520 granted patents across 92 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

RSS updates for this company

The verdict

According to USPTO PatentsView, Fresenius ranks #868 of 49,997 tracked US assignees by granted-patent volume, with 520 patents across 92 technology areas.

#868
of 49,997 US assignees by volume
Top 1%
by Innovation Score (65.4/100)
19.0
avg claims per patent
+50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R868 · US Corporation #868 · 520 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MID 520 grants
  • TOP-DECILE #868/49,997
  • PHOTO-FINISH China Academy OF…
  • CPC-WIDE A61M · 92 areas
  • INNOV-STRONG 65.4/100
  • CLAIMS-RICH 19.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +50% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: China Academy OF Telecommunications Technology (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Fresenius

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Fresenius's Innovation Score is 65.4/100 (top 1% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

How Fresenius's grant cadence moved

Between 2020–2024, Fresenius Medical Care Holdings, Inc. received 289 grants versus 193 in 2015–2019 (+50% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2022 at 66 grants and bottomed in 2016 at 31. Lead class A61M accounts for 83.7% of the portfolio across 92 subclasses. Volume neighbours: Transportation IP Holdings, LLC (#864) and PepsiCo, Inc. (#872).

Fresenius's three-year grant acceleration

From 2019–2021 to 2022–2024, Fresenius Medical Care Holdings, Inc. moved from 163 to 180 grants (1.10x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #952. See the growth leaderboard.

Who files at Fresenius's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Fresenius holds 520 patents at rank #868, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Fresenius

By rank, the assignees closest to #868 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Fresenius's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Fresenius, neither rank-band nor same-CPC leaders (those blocks stay above).

Fresenius's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

65 Top 1% higher than 99% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

203040506070 20152016201720182019202020212022202320242025 38
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Fresenius Medical Care Holdings, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 37 7.1%
2016 31 6.0%
2017 40 7.7%
2018 31 6.0%
2019 54 10.4%
2020 58 11.2%
2021 51 9.8%
2022 66 12.7%
2023 54 10.4%
2024 60 11.5%
2025partial year 38 7.3%

Which technologies does Fresenius Medical Care Holdings, Inc. patent most?

Top 15 of 92 technology areas

Where it ranks

Overall rank by patents

#868

of 49,997 tracked assignees

Innovation Score

65.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Fresenius Medical Care Holdings, Inc.'s patent record in context - here's where to go next.

  • Fresenius Medical Care Holdings, Inc.'s lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 83.7% of its portfolio - see every assignee active in that class. Explore A61M
  • Ranked #868 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Fresenius Medical Care Holdings, Inc. against Transportation IP Holdings, LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 65.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.